https://www.pharmanow.live/latest-news/alkem-launches-renocia-exo-india-first-patented-ginsenoside-exosome-hair-growth-serum 2026-09-08T23:00:00+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Alkem Launches Renocia Exo, India's First Patented Ginsenoside Exosome Hair Growth Serum Alkem https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/972c675a-8036-49f2-a4c7-90bf1fcc29fd/883085c7-f65d-468e-9c35-2ea39d577b23.png https://www.pharmanow.live/latest-news/ocugen-doses-first-patient-phase-3-armada3-trial-ocu410-geographic-atrophy 2026-09-08T23:01:06+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Ocugen Doses First Patient in Phase 3 ArMaDa3 Trial of OCU410 for Geographic Atrophy Ocugen https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/972c675a-8036-49f2-a4c7-90bf1fcc29fd/3514ac20-854b-4252-9957-ee48ad4e48cf.png https://www.pharmanow.live/latest-news/biocon-secures-10-year-pertuzumab-supply-deal-brazil-pdp-framework 2026-09-08T23:00:36+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Biocon Secures 10-Year Pertuzumab Supply Deal with Brazil Under PDP Framework Biocon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/972c675a-8036-49f2-a4c7-90bf1fcc29fd/232930b8-fe82-49b0-bf81-14a73254b75b.png https://www.pharmanow.live/latest-news/veru-advances-sabizabulin-phase-2-daraxonrasib-resistant-pancreatic-cancer 2026-09-08T23:01:47+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Veru Advances Sabizabulin into Phase 2 After Preclinical Data Shows Activity in Daraxonrasib-Resistant Pancreatic Cancer Veru https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/972c675a-8036-49f2-a4c7-90bf1fcc29fd/32d7d93e-fe1f-45a9-ab55-1d3853c51cec.png https://www.pharmanow.live/latest-news/gri-bio-phase-2a-gri-0621-nine-pillar-mechanism-ipf-ers-2026 2026-09-08T22:56:54+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 GRI Bio Presents Phase 2a Data Mapping GRI-0621's Nine-Pillar Mechanism of Action in IPF https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.globenewswire.com/newsroom/ti?nf=OTgyMjY1MSM3ODIxODMxIzUwMDA3NTQ4OA== https://www.pharmanow.live/latest-news/pmv-pharmaceuticals-appoints-philip-herman-cco-rezatapopt-nda-2027 2026-09-08T22:57:49+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 PMV Pharmaceuticals Appoints Philip Herman as CCO Ahead of 2027 Rezatapopt NDA Submission PMV https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/972c675a-8036-49f2-a4c7-90bf1fcc29fd/5f7d2848-abf1-4dd9-b55f-289e2ccf8a79.png https://www.pharmanow.live/latest-news/infex-therapeutics-phase-iia-resp-x-pseudomonas-bronchiectasis-ers-2026 2026-09-08T13:43:29+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Infex Therapeutics Reports Phase IIa Signal in Bronchiectasis Infex Therapeutics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/58334c76-f1b4-4f02-a3c3-00b6b61c284c/0e3c3a61-1f31-43c4-8f01-74c6ce506fda.png https://www.pharmanow.live/latest-news/novartis-harbor-phase-iii-misses-primary-endpoint-dm1-del-desiran 2026-09-08T13:43:44+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Novartis HARBOR Phase III Trial Misses Primary Endpoint Novartis https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/58334c76-f1b4-4f02-a3c3-00b6b61c284c/b6b12a83-f0d2-4fe9-ae3e-d8f56db3bd26.png https://www.pharmanow.live/latest-news/cormica-opens-medical-device-chemistry-lab-bradford-centre-of-excellence 2026-09-08T13:43:47+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 Cormica Opens Medical Device Chemistry Lab in Bradford Cormica https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.cormica.com/wp-content/uploads/2026/09/cormica-bradford-medical-device-chemistry-laboratory-opening-600x600.jpg https://www.pharmanow.live/latest-news/hrv-pharma-rs-150-crore-synthetic-peptides-hpapi-oncology-expansion 2026-09-08T13:43:34+05:30 Pharma Now en 2026-09-08T00:00:00+05:30 HRV Pharma Commits Rs. 150 Crore to Build API Capacity HRV Pharma https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4e4f9cbb-caec-4513-9cd6-9a4df79b146b/cabe9bdc-0521-4789-b28c-d438dce85c43.png https://www.pharmanow.live/latest-news/sanofi-tricog-ai-cardiac-diagnostics-partnership 2026-09-08T15:37:54+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Sanofi Signs Three-Year Partnership with Tricog to Scale AI Cardiac Diagnostics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/sanofi-tricog-ai-cardiac-diagnostics-partnership20260908143207.webp https://www.pharmanow.live/latest-news/pfizer-discontinues-minipress-xl-global-manufacturing-cessation 2026-09-08T15:43:44+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Pfizer Discontinues Minipress XL Following Global Manufacturing Cessation Decision https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/pfizer-discontinues-minipress-xl-manufacturing20260908154327.webp https://www.pharmanow.live/latest-news/novo-nordisk-step-young-phase-3-pediatric-semaglutide-obesity 2026-09-08T15:46:24+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Novo Nordisk Achieves Primary Endpoint in STEP Young Phase 3 Trial for Pediatric Semaglutide Indication https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/novo-nordisk-step-young-pediatric-semaglutide-obesity20260908154615.webp https://www.pharmanow.live/latest-news/astrazeneca-fda-accelerated-approval-breast-cancer-serena-6 2026-09-08T15:50:35+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 AstraZeneca Wins FDA Nod After SERENA-6 Cuts Progression Risk 56% AstraZeneca https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/astrazeneca-fda-accelerated-approval-serena-6-breast-cancer20260908155021.webp https://www.pharmanow.live/latest-news/fosun-pharma-hk1-billion-h-share-buyback-gland-pharma-stake-disposal 2026-09-08T15:54:55+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Fosun Pharma Secures HK$1B H-Share Buyback via Gland Stake Sale Fosun Pharma https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fosun-pharma-hk1-billion-buyback-gland-pharma-stake20260908155440.webp https://www.pharmanow.live/latest-news/indian-immunologicals-abhayrab-quality-dispute-cdsco-batch-records 2026-09-07T11:07:07+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Indian Immunologicals Disputes Abhayrab Findings, Submits Records Indian Immunologicals https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e0d7c157-6648-4d52-b1b0-68ccb7465d87/6f0e8972-e93a-480e-8821-a8be9374f779.png https://www.pharmanow.live/latest-news/rezubio-fda-nmpa-ind-clearances-rz-520-chronic-respiratory-disease 2026-09-08T15:58:55+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Rezubio Gains FDA, NMPA IND Clearances for Inhaled RZ-520 Rezubio https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/rezubio-fda-nmpa-ind-clearances-rz-52020260908155844.webp